The Sheffield center is poised to enhance gene therapy research both in the UK and globally, leveraging a collaborative network of researchers and partners.

The University of Sheffield has officially launched the Gene Therapy Innovation and Manufacturing Centre (GTIMC), marking a significant advancement in the field of gene therapy.

The inauguration ceremony was attended by notable figures, including Princess Anne and Morocco's ambassador to the UK, Hakim Hajoui.

This new center aims to accelerate the clinical development of innovative genetic treatments by producing clinical-grade vectors and offering translational support and regulatory advice.

Professor Mimoun Azzouz, who leads the center, emphasized that gene therapy holds promise for treating over 7,000 rare and hereditary diseases that currently lack effective cures.

Professor Azzouz brings a wealth of experience to the role, holding a PhD in neuropharmacology and having previously worked at the gene therapy center in Lausanne and Oxford BioMedica plc.

He has authored numerous research projects in gene therapy and neurodegenerative diseases, earning several international awards for his contributions.

Since joining the University of Sheffield in 2006, Professor Azzouz has been instrumental in advancing translational neuroscience and fostering research innovation.

The University of Sheffield is recognized for its research in neurodegenerative diseases and is emerging as a key player in the gene therapy landscape.